UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial

Journal of clinical oncology, 2018-03, Vol.36 (9), p.875-883

2018

Volltextzugriff (PDF)

Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial

Breast cancer research : BCR, 2018-10, Vol.20 (1), p.124-124, Article 124

2018

Volltextzugriff (PDF)

Aerobic and Resistance Exercise Improves Shoulder Function in Women Who Are Overweight or Obese and Have Breast Cancer: A Randomized Controlled Trial

Physical therapy, 2019-10, Vol.99 (10), p.1334-1345

2019

Volltextzugriff (PDF)

Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women

Cancer prevention research (Philadelphia, Pa.), 2012-03, Vol.5 (3), p.393-402

2012

Volltextzugriff (PDF)

Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib

NPJ breast cancer, 2022-02, Vol.8 (1), p.22-22, Article 22

2022

Volltextzugriff (PDF)

Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone

BioMed research international, 2015-01, Vol.2015 (2015), p.1-9

2015

Volltextzugriff (PDF)

Biological effects of green tea capsule supplementation in pre-surgery postmenopausal breast cancer patients

Frontiers in oncology, 2013-01, Vol.3, p.298-298

2013

Volltextzugriff (PDF)

Preoperative Twice-Weekly Paclitaxel With Concurrent Radiation Therapy Followed by Surgery and Postoperative Doxorubicin-Based Chemotherapy in Locally Advanced Breast Cancer: A Phase I/II Trial

Journal of clinical oncology, 2003-03, Vol.21 (5), p.864-870

2003

Volltextzugriff (PDF)

Decreasing time to initiation of inpatient chemotherapy at LAC+USC medical center utilizing an admission checklist

Journal of clinical oncology, 2019-09, Vol.37 (27_suppl), p.262-262

2019

Volltextzugriff (PDF)

Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 Carriers

Clinical cancer research, 2007-01, Vol.13 (2), p.654-658

2007

Volltextzugriff (PDF)

Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial

Contraception (Stoneham), 2012-09, Vol.86 (3), p.238-243

2012

Volltextzugriff (PDF)

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

The lancet oncology, 2020-04, Vol.21 (4), p.519-530

2020

Volltextzugriff (PDF)

Abstract PO-276: Lazarex Cancer Foundation (LCF) financial reimbursement programs (FRP) promote equitable access and inclusion among racial/ethnic minorities in therapeutic cancer clinical trials (TCT)

Cancer epidemiology, biomarkers & prevention, 2020-12, Vol.29 (12_Supplement), p.PO-276-PO-276

2020

Volltextzugriff (PDF)

Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study

Breast cancer research and treatment, 2020-07, Vol.182 (2), p.451-463

2020

Volltextzugriff (PDF)

Adipose tissue inflammation in breast cancer survivors: effects of a 16-week combined aerobic and resistance exercise training intervention

Breast cancer research and treatment, 2018-02, Vol.168 (1), p.147-157

2018

Volltextzugriff (PDF)

Measuring the long commute: Experiences of a multi-ethnic cohort of patients enrolled in a financial reimbursement program for cancer clinical trials

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18568-e18568

2022

Volltextzugriff (PDF)

Utilization of a multisite financial reimbursement program to promote racial/ethnic diversity and inclusion in therapeutic cancer clinical trials: The iMPACT Study

Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.85-85

2020

Volltextzugriff (PDF)

Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions

Oncogene, 2023-02, Vol.42 (9), p.627-637

2023

Volltextzugriff (PDF)

A phase 1 trial in progress for in situ immunomodulation with CDX-301, radiation therapy, poly-ICLC, and CDX-1140 in patients with unresectable and metastatic solid tumors

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.TPS2697-TPS2697

2024

Volltextzugriff (PDF)

Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk

Epidemiologic reviews, 1993, Vol.15 (1), p.17-30

1993

Volltextzugriff (PDF)

Aerobic and resistance exercise improve patient-reported sleep quality and is associated with cardiometabolic biomarkers in Hispanic and non-Hispanic breast cancer survivors who are overweight or obese: results from a secondary analysis

Sleep (New York, N.Y.), 2021-10, Vol.44 (10), p.1

2021

Volltextzugriff (PDF)

Is there a role for 21-gene recurrence score in mucinous carcinoma of breast?

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e12538-e12538

2018

Volltextzugriff (PDF)

Abstract 4459: Morphologic and genomic characterization of circulating tumor cells in patients with ERBB2 mutant HER2 non-amplified metastatic breast cancer treated with neratinib

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4459-4459

2019

Volltextzugriff (PDF)

Phase II trial of metronomic capecitabine and cyclophosphamide with lapatinib and trastuzumab in patients with HER2-positive metastatic breast cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e12508-e12508

2019

Volltextzugriff (PDF)

Comprehensive characterization of androgen receptor expression in breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1035-1035

2023

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Aktive Filter

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(92)

Publikationsform

Sprache

Englisch
(99)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(50)
Science & Technology
(50)
Humans
(46)
Female
(43)
Oncology
(36)
Adult
(29)
Middle Aged
(29)
Breast Cancer
(21)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Pharmacology. Drug Treatments
(16)
Aged
(15)
Antineoplastic Agents
(12)
Chemotherapy
(11)
Breast Neoplasms - Prevention & Control
(9)
Breast Neoplasms - Therapy
(9)
Risk Factors
(9)
Breast Neoplasms - Epidemiology
(8)
Exercise
(8)
Male
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial

Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial

Aerobic and Resistance Exercise Improves Shoulder Function in Women Who Are Overweight or Obese and Have Breast Cancer: A Randomized Controlled Trial

Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women

Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib

Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone

Biological effects of green tea capsule supplementation in pre-surgery postmenopausal breast cancer patients

Preoperative Twice-Weekly Paclitaxel With Concurrent Radiation Therapy Followed by Surgery and Postoperative Doxorubicin-Based Chemotherapy in Locally Advanced Breast Cancer: A Phase I/II Trial

Decreasing time to initiation of inpatient chemotherapy at LAC+USC medical center utilizing an admission checklist

Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 Carriers

Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Abstract PO-276: Lazarex Cancer Foundation (LCF) financial reimbursement programs (FRP) promote equitable access and inclusion among racial/ethnic minorities in therapeutic cancer clinical trials (TCT)

Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study

Adipose tissue inflammation in breast cancer survivors: effects of a 16-week combined aerobic and resistance exercise training intervention

Measuring the long commute: Experiences of a multi-ethnic cohort of patients enrolled in a financial reimbursement program for cancer clinical trials

Utilization of a multisite financial reimbursement program to promote racial/ethnic diversity and inclusion in therapeutic cancer clinical trials: The iMPACT Study

Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions

A phase 1 trial in progress for in situ immunomodulation with CDX-301, radiation therapy, poly-ICLC, and CDX-1140 in patients with unresectable and metastatic solid tumors

Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk

Aerobic and resistance exercise improve patient-reported sleep quality and is associated with cardiometabolic biomarkers in Hispanic and non-Hispanic breast cancer survivors who are overweight or obese: results from a secondary analysis

Is there a role for 21-gene recurrence score in mucinous carcinoma of breast?

Abstract 4459: Morphologic and genomic characterization of circulating tumor cells in patients with ERBB2 mutant HER2 non-amplified metastatic breast cancer treated with neratinib

Phase II trial of metronomic capecitabine and cyclophosphamide with lapatinib and trastuzumab in patients with HER2-positive metastatic breast cancer

Comprehensive characterization of androgen receptor expression in breast cancer

Aktive Filter

Suchergebnisse filtern